GALAXY Study Results: ctDNA Status Predicts Outcomes and Treatment Benefit in CRC

Opinion
Video

Panelists discuss how results from the GALAXY study reveal that circulating tumor DNA (ctDNA) status is a powerful predictor of outcomes and treatment benefit in patients with colorectal cancer (CRC), potentially revolutionizing personalized treatment approaches.

Recent Videos
Related Content